Analyse de mortalitate in cura critic neonatal

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson
Download our mobile app to listen on the go
Get App

Questions and Answers

Qual es le cambio in le rata de mortalitate crude in cura critic inter le total de 12 menses del anno currente e le periodo comparative de 24 menses?

  • Un augmento de approximativemente 26.29%
  • Un reduction de approximativemente 25.09% (correct)
  • Un augmento de approximativemente 39.88%
  • Un reduction de approximativemente 10.58%

Qual es le consequentia del methodo de reportar le cifras super le data de nascentia, como se applica al numero de casos capturate in le Rete Vermont Oxford (VON)?

  • Le cifras remane constante e non es subjecte a revision.
  • Le cifras se reporta solmente pro le casos con pesos de nascentia expandite.
  • Le cifras cambia retrospectivemente quando le casos es capturate super VON post le discarga. (correct)
  • Le cifras es solmente relevante pro le indicadores de cura critic neonatal.

Qual es le implication del indice de mortalitate (SAPS3) de 2.85 in Januario 2025 comparate con 1.00 del anno currente precedente quanto al mortalitate relative?

  • Le mortalitate relative ha remanite static.
  • Le mortalitate relative ha monstrate un fluctuation minimal.
  • Le mortalitate relative ha diminuite significativamente.
  • Le mortalitate relative ha augmentate substantialmente. (correct)

Si le numero de casos de mortalitate expectate augmenta dramaticamente, qual es le consequentia le plus probabile super le indice de mortalitate (SAPS3), supponente que le casos de mortalitate observate remane constante?

<p>Le indice de mortalitate (SAPS3) diminuera. (C)</p> Signup and view all the answers

In le contexto del cura critic neonatal, si le numero de casos de mortalitate (excludente le casos in le peso de nascentia expandite) remane a zero, qual poterea esser un conclusion re le qualitate del cura?

<p>Poterea esser fallimentos in le reporto de casos de mortalitate. (D)</p> Signup and view all the answers

Qual es le impacto de un reduction in le numero de casos capturate super SAPS3 super le fiabilitate del datos usate pro calcular le rata de mortalitate in cura critic?

<p>Diminue le fiabilitate proque le grandor del provision de datos es plus parve. (C)</p> Signup and view all the answers

Considerante que le numero de casos de mortalitate in cura critic neonatal es zero, si le numero de casos capturate super VON es reducite, qual poterea esser un consequentia re le analyse de resultatos e le comparationes?

<p>Illac es un risco de conclusiones imprecise e potentialmente false. (D)</p> Signup and view all the answers

Que indica un augmento del 61.54% in le numero de mortalitates in cura critic inter le periodo de referentia e le menses currente?

<p>Un potential deterioration in le qualitate del cura o factores externe adversari. (C)</p> Signup and view all the answers

Considerante le datos providite, qual del sequente classe de antimicrobiales ha demonstrate le plus alte augmento in utilisation, mesurate in Rata per 100 Dies Patien?

<p>Echinocandins (B)</p> Signup and view all the answers

Qual es le importantia de evaluar le rata de uso de antimicrobiales per 100 dies de patiente in hospitales?

<p>Permitter comparationes directe de uso de antimicrobiales inter hospitales de differente dimensiones e cargas de patientes (D)</p> Signup and view all the answers

Qual es le implicationes potential de un declino in le rata de exposition per 1.000 expositiones?

<p>Un potential declino in le vigilantia de infectiones o cambios in practicas de reportation (C)</p> Signup and view all the answers

Basate super le datos, qual tendentia es observabile in le utilisation total de antimicrobiales, considerando le Doses Diari Definite (DDD's)?

<p>Un augmento, ma con fluctuations dependente del antimicrobiale specific (B)</p> Signup and view all the answers

Suppone que un hospital observa un augmento substantial in le uso de carbapenems. Qual actiones debe esser considerate pro gerer iste tendentia?

<p>Implementar un programma de administration de antimicrobiales focalisate in reducer le utilisation de carbapenems (B)</p> Signup and view all the answers

Wie pote informationes del utilisation de antibioticos adjutar programmation de hospitales e clinicas?

<p>In guidar creation de politicas e guidas pro prescribente e mitigar resistentia a medicina. (D)</p> Signup and view all the answers

Considerante le contextos clinic, proque es importante monitorar le utilisation de antimicrobiales como Polymyxin (Colistin e Polymyxin B)?

<p>Polymyxins son antimicrobiales de reserva associate con toxicitate significative e le resistentia pote emerger (A)</p> Signup and view all the answers

Qual es le beneficio de comparar curationes mensual de antimicrobiales durante comparationes de 12 menses?

<p>Suavisa le fluctuationes de curte terme e revelar tendentias plus importante e patronos in le consumo de antimicrobiales (B)</p> Signup and view all the answers

Qual es le impacto del reduction in dies de ventilator super le rata de pneumonias associate al ventilator (VAP)?

<p>Un reduction in dies de ventilator pote mascar un rata de VAP augmentate si le infectiones remane constante o augmenta. (A)</p> Signup and view all the answers

Qual factor pote contribuer le plus significante al augmento del infectiones associate al curas de sanitate (HAI)?

<p>Un reduction del adherentia al hygiene del manos (B)</p> Signup and view all the answers

Si un hospital constatava un augmento in infectiones del fluxo sanguinee associate al linea central (CLABSIs) malgrado un augmento in dies de linea central, qual conclusion pote esser derivate?

<p>Le practica aseptic pro insertion e mantenimento del linea central ha possibilemente declinate. (D)</p> Signup and view all the answers

Qual es le implication de un rata de infection del sito chirurgic (SSI) plus alte per 1.000 casos operative?

<p>Plus alte probabilitate de complicationes, hospitales plus longe, e plus alte costos de curas de sanitate. (C)</p> Signup and view all the answers

Qual strategia adressa le plus directemente le reduction del infectiones del tracto urinari associate al catheter (CAUTI)?

<p>Meliorar le adherentia al hygiene del manos e assecurar que es inserite catheteres solmente quando clinicamente necessari. (C)</p> Signup and view all the answers

Qual es le impacto directe de un programma effective de hygiene del manos sur objectivos del curas de sanitate?

<p>Reduce le propagation de infectiones, meliora le securitate del patiente, e diminue le costos de curas de sanitate. (A)</p> Signup and view all the answers

Le qual del sequente actiones es plus crucial pro diminue le incidentia de pneumonias associate al ventilator (VAP)?

<p>Mantener un higiene oral adequate e elevation del capite del lecto pro patientes intubate. (D)</p> Signup and view all the answers

Como pote un hospital plus effectivemente reducer le ratas de infection in general, basate solmente super le date date?

<p>Implementar strategias comprehensive que adresse cata typo de infection, adaptar interventiones basate super le dato plus recente disponibile. (B)</p> Signup and view all the answers

Qual calculation representa le melior maniera de evalutar le efficacia del programma de stewardship antimicrobial in relation al uso de prophylaxis?

<p>Observer le evolution del rata de prophylaxe inappropriate. (B)</p> Signup and view all the answers

Qual es le signification del comparationes de '12 menses continuate' in le contexto del reporto de datos?

<p>Illos summara le datos de 12 menses consecutive pro provider un vista general del evolutiones con le tempore. (C)</p> Signup and view all the answers

Qual typicamente es le prime passo a prender si le rata de infectiones del sito chirurgic post le reimplaciamento de coxas excede le scopo predefinite?

<p>Investigar le rationes specific detra le valores elevate e adaptar le strategias de prevention. (C)</p> Signup and view all the answers

Qual impacto directemente mesura le auditoria del stewardship antimicrobial super le casos de prophylaxe inappropriate?

<p>Amelioration del adherencia al guias clinic. (C)</p> Signup and view all the answers

In le contexto del reporto, qual es un beneficio primari de usar un 'tendentia' statistic pro analyse del datos?

<p>Illo permitte le identification de patronos e evolutiones significative con le tempore. (B)</p> Signup and view all the answers

Qual mesura indica le probabilitate que un patiente contrahe MRSA durante que reciper cura medic?

<p>Rata de MRSA associato al cura sanitari per 100.000 PD (D)</p> Signup and view all the answers

Quale del sequente propositiones es le plus importante quando se analyse le datos re infectiones del sito chirurgic?

<p>Prender in conto le characteristicas del patiente, le typo de intervention chirurgic e altere factores de risco pertinente. (A)</p> Signup and view all the answers

In que maniera le information 'CONFIDENTIAL' super le reporto affectaria le actiones de un administrator hospitalari?

<p>Il illes debe limitar le distribution del reporto al personal directemente involvite in le melioration del qualitate. (B)</p> Signup and view all the answers

Qual es le consequentia de un reduction significative in le indice de severitate (SI) durante le ultime 24 menses?

<p>Reduction del complexitate relative del casos obstetric. (C)</p> Signup and view all the answers

Qual effecto ha un reduction de 100% in le mortalitates de patientes de parturition super le rata de mortalitate per 100.000 nascimentos vive?

<p>Un reduction absolute a zero in le rata de mortalitate. (B)</p> Signup and view all the answers

Como le alteramentos in le rata de section caesarean influe super le practica obstetric, supponente que il ha un reduction appreciable durante le ultime 24 menses?

<p>Il es probabile que minus ressources debe esser allocate a curationes postoperatori. (C)</p> Signup and view all the answers

Qual es un implication potential de nulle casos de ruptura uterin reportate durante le periodos recente?

<p>Necessita reducite pro intervention chirurgic urgente. (D)</p> Signup and view all the answers

Qual aspecto del cura neonatal es indicate per un significant reduction in le admissiones neonatal al NICU?

<p>Minder stress super le recursos del NICU. (A)</p> Signup and view all the answers

Como le alteramentos in le Scora de Resultato Adverse Ponderate (WAOS) reflue super le qualitate del cura obstetric?

<p>Un reduction significa un cura meliorate. (B)</p> Signup and view all the answers

Qual factores poterea contribuer a nulle casos de trauma de nascentia reportate?

<p>Interventiones obstetric meliorate e cura. (B)</p> Signup and view all the answers

Proque es le rata de admissiones maternal non planificate al ICU importante pro evalutar?

<p>Illo reflecte le complexitate del casos obstetric e securitate del patiente. (B)</p> Signup and view all the answers

Como le numero de nascentias vive relative al numero de parturitiones pote influer super le interpretation de altere indicatores?

<p>Un discrepantia grande pote indicar errores de reportation o complicationes significative. (D)</p> Signup and view all the answers

Quando evalutar le effecto de interventiones pro meliorar resultados obstetric, proque es importante considerar le scala temporal (e.g., 24-menses) del datos?

<p>Resultatos benific se pote devenir plus clar o disparer con plure tempore. (D)</p> Signup and view all the answers

Qual del sequente optiones melio representa le calculation del variation percentage in le rata de mortalitate inter duo periodos?

<p>Divider le differentia inter le ratas de mortalitate per le rata de mortalitate del periodo precedente, e multiplicar per 100. (C)</p> Signup and view all the answers

Si le rata de infection tardive cambia de 2% a 1,10%, qual es le implication pro le cura neonatal?

<p>Ben que le rata ha diminuite, le practicas curate debe esser mantenite o intensificate a causa del impacte potential de infectiones tardive. (B)</p> Signup and view all the answers

Qual es le impacto potential plus significative de un rata de 0% pro Bronchopulmonar Dysplasia Chronic (CLD) in infantes prematur (minus que 33 septimanas de gestation)?

<p>Un reduction in le necessitate pro supporto respiratori a longe termino post le discarga. (A)</p> Signup and view all the answers

Le absentia de casos de Hemorragia Intraventricular Sever (IVH) e Leucomalacia Periventricular Cystic (PVL) inter infantes prematur indica:

<p>Protocollos de cura perinatal e neonatal efficace que reduce le risco de lesiones cerebral. (C)</p> Signup and view all the answers

Si un hospital reporta un rata de examination retinal de 87% in Neonatos de Basse Peso Extrememente Basse (VLBW) in un periodo, ma 0% in le sequente, qual action es le plus appropriate?

<p>Investigar le causa del cambio subite pro assecurar se que omne infantes eligibile reciper examinationes. (C)</p> Signup and view all the answers

Qual es le implication de non haber reportate casos de Enterocolite Necrotic (NEC)?

<p>Necessita un revision comprehensibile del protocollos de alimentation e monitorage pro assecurar se que le datos es accurate e que le practicas son secur. (C)</p> Signup and view all the answers

Un augmento marcate in 'Casos total de Mortalitate o Morbiditate' accompaniate de un reduction in '% Tasa de Mortalitate', compara con periodos precedente, pote ser attribuite a:

<p>Un augmento substantial in morbiditate con solmente un augmento marginal de mortalitate inter le cohorto. (C)</p> Signup and view all the answers

Le presentia de 'Datos Confidential' in le documento pro comparisones mensual implica que:

<p>Le datos debe esser tractate con cura e non esser distribuite excepte intra canales autorisate. (D)</p> Signup and view all the answers

Si le procentaje reportate pro 'Examination Retinal (VLBW)' es 0%, qual poterea esser un impacto potential super longe termino super le population infantil?

<p>Un augmento in le incidentia de cecitate infantil prevenibile debite al diagnose o tractamento retardate de ROP. (C)</p> Signup and view all the answers

Qual strategia es le plus appropriate pro le 'Analytica e Reportation del Departimento' a Mediclinic International si il ha discrepantia significative inter reportos retrospective e curate?

<p>Investigar le discrepantia pro identifier le causa radice e implementa mesuras corrective pro le collection e reporto del datos. (A)</p> Signup and view all the answers

Flashcards

Tarifa de Compliantia de Hygienie de Manus

Le perchentage de observationes ubi personal sanitari adhere al protocolos de higiene de manos.

Infectiones Associate con Cura Sanitari (HAI)

Infectiones que patientes recipe durante que illes es recipiente cura medical pro un altere condition.

Tarifa de HAI per 1,000 Dies de Patiente

Le numero de HAI per 1,000 dies de patiente.

Pneumonia Associate con Ventilator (VAP)

Pneumonia in patientes sub ventilation mechanic.

Signup and view all the flashcards

Infection del Sanguine Associate con Linea Central (CLABSI)

Infection del sanguine associate con un linea central (catheter in un vena major).

Signup and view all the flashcards

Infection del Tracto Urinari Associate con Catheter (CAUTI)

Infection del tracto urinari associate con le uso de un catheter urinari.

Signup and view all the flashcards

Infection de Sito Chirurgic (SSI)

Infection que occurre post chirurgia in le parte del corpore ubi le chirurgia era effectuate.

Signup and view all the flashcards

Tarifa de SSI per 1,000 Casos Operatori

Le numero de SSI per 1,000 casos operatori.

Signup and view all the flashcards

Rate de Hysterectomias

Le numero de hysterectomias per 1,000 procedures.

Signup and view all the flashcards

SSI (CABG)

Le numero de infectiones al sito chirurgic per 1,000 bypasses coronari.

Signup and view all the flashcards

SSI (Reimplaciamentos de Geniculo)

Le numero de infectiones al sito chirurgic per 1,000 reimplaciamentos de geniculo.

Signup and view all the flashcards

SSI (Reimplaciamentos de Hanche)

Le numero de infectiones al sito chirurgic per 1,000 reimplaciamentos de hanche.

Signup and view all the flashcards

SSI (Sectiones Caesarean)

Le numero de infectiones al sito chirurgic per 1,000 sectiones caesarean.

Signup and view all the flashcards

MRSA

Staphylococcus aureus resistente a methicillina.

Signup and view all the flashcards

MRSA (Associate al Cura Sanitari)

MRSA associate con le cura de sanitate.

Signup and view all the flashcards

Casos Inappropriate de Prophylaxe

Casos inappropriate de prophylaxe antimicrobial.

Signup and view all the flashcards

Rate per 1,000 Expositiones

Le numero de vices un persona es exposto a un intervention medic per 1,000 personas.

Signup and view all the flashcards

Total Uso Antimicrobial (DDD)

Un systema de mesura del quantitate total de antibioticos usate.

Signup and view all the flashcards

Rate de Uso Antimicrobial per 100 PD

Le uso de antibioticos per 100 patiente-dies.

Signup and view all the flashcards

Utilisation de Doses Definite Targetate (DDD)

Uso specific de antibioticos como Polymyxin.

Signup and view all the flashcards

Carbapenems (DDD)

Un classe de antibioticos potente usate pro infectiones difficile.

Signup and view all the flashcards

Cephalosporins de Tertie Generation (DDD)

Un gruppo de antibioticos commun.

Signup and view all the flashcards

Fluoroquinolone (DDD)

Un typo de antibiotico.

Signup and view all the flashcards

Echinocandins (DDD)

Medicamentos antifungal que tracta infectiones fungal.

Signup and view all the flashcards

Numero de casos sur SAPS3

Le numero de casos registrate sur SAPS3.

Signup and view all the flashcards

Numero de mortes in cura critic

Le numero de mortes in cura critic.

Signup and view all the flashcards

Rata Crude de Mortalitate - Cura Critic

Le rata crude de mortalitate in cura critic (in percentaje).

Signup and view all the flashcards

Numero de casos de mortalitate expectate

Numero de casos de mortalitate expectate.

Signup and view all the flashcards

Rata de Mortalitate Expectate - Cura Critic

Rata de mortalitate expectate in cura critic (in percentaje).

Signup and view all the flashcards

Indice de Mortalitate (SAPS3)

Un indice que compara le mortalitate observate con le mortalitate expectate.

Signup and view all the flashcards

Numero de casos registrate sur VON

Le numero de casos registrate sur le Vermont Oxford Network (VON).

Signup and view all the flashcards

Numero de casos de mortalitate

Le numero de casos de mortalitate in le unitate de cura critic neonatal.

Signup and view all the flashcards

Tarifa de Mortalitate

Le numero de mortes que occurre in un population specific durante un periodo de tempore specific.

Signup and view all the flashcards

Casos de Morte o Morbiditate

Casos de morte o maladia in un population specific.

Signup and view all the flashcards

Tarifa de Morte o Morbiditate

Le perchentage de casos de morte o maladia in un certe population.

Signup and view all the flashcards

Infectiones Tardive

Infectiones que occurre post le periodo neonatal initial.

Signup and view all the flashcards

Enterocolite Necrotisante

Un inflammation sever del intestino, particularmente in neonatos premature.

Signup and view all the flashcards

Maladia Pulmonar Chronic

Maladia pulmonar chronic in infantes nate prematuramente (ante 33 septimanas de gestation).

Signup and view all the flashcards

Pneumothorace

Collection de aere in le spatio inter le pulmone e le pariete thoracic.

Signup and view all the flashcards

Hemorragia Intraventricular Severe (HIV)

Hemorragia in le ventriculos del cerebro, frequentemente occurrente in infantes premature.

Signup and view all the flashcards

Leukomalacia Periventricular Cystic (LPVC)

Damno al materia albe del cerebro que resulta in formation de cystes.

Signup and view all the flashcards

Examination Retinal (VLBW)

Un examination del retina pro deteger problemas in neonatos de basso peso al nascentia (VLBW).

Signup and view all the flashcards

Numero de Parturitiones

Le numero total de parturitiones durante un periodo specific.

Signup and view all the flashcards

Numero de Nascentias Vive

Le numero total de nascentias vive durante un periodo specific.

Signup and view all the flashcards

Section Caesarean (%)

Le perchentage de parturitiones que es effectuate per section caesarean.

Signup and view all the flashcards

Score de Resultato Adverse Ponderate (WAOS)

Un score que evaluta le resultatos adverse in obstetricia.

Signup and view all the flashcards

Indice de Resultato Adverse (AOI)

Un indice que indica le frequentia de resultatos adverse.

Signup and view all the flashcards

Indice de Severitate (SI)

Mesura le gravitate del resultatos adverse.

Signup and view all the flashcards

Numero de Mortes Neonatal

Le numero de mortes neonatal.

Signup and view all the flashcards

Rata de Mortalitate Neonatal per 1,000 Nascentias Vive

Le rata de mortalitate neonatal per 1,000 nascentias vive.

Signup and view all the flashcards

Mortalitates de Patientes de Parturition

Numero de mortes de patientes durante parturition.

Signup and view all the flashcards

Rata de Mortalitate de Parturition per 100,000 Nascentias Vive

Le rata de mortalitate de parturition per 100,000 nascentias vive.

Signup and view all the flashcards

Study Notes

  • Mediclinic Newcastle.
  • Clinical Indicator Report.
  • Results for the period ending January 2025.

Section A: Clinical Performance Indicator Detail

Operational Overview

  • Hospital admissions were 12,573, a 4.54% increase.
  • Daycases numbered 1,168, a 2.83% decrease.
  • Inpatient (Overnight) cases totaled 11,405, a 5.36% increase.
  • Daycase/Inpatient Split: 9/91%.
  • Medical cases amounted to 7,000, a 2.62% increase.
  • Surgical cases: 5,573, a 7.05% increase.
  • Medical/Surgical Split: 56/44%.
  • Emergency Centre cases: 9,492, reflecting a -6.14% change.
  • Ambulatory/Outpatient cases: 90, down -32.84%.
  • Vaccines Administered: 0.
  • Outpatient Cases excluding vaccinations: 90, down -32.84%.

Volumes for Selected Acute Care Procedures/Diagnosis (Hospital)

Medical Admissions

  • Abortions/Miscarriages: 137, rose 29.25%.
  • Acute Bronchitis: 143, down -16.37%.
  • Acute Myocardial Infarctions: 96, down -22.58%.
  • Depression: 929, down -0.54%.
  • Gastroenteritis Infections: 958, rose 0.31%.
  • Normal Deliveries: 226, rose 15.31%.
  • Pneumonia: 943, rose 2.28%.
  • Septicaemia/Sepsis: 918, down -0.97%.
  • Strokes: 160, down -10.61%.
Stroke Subtypes
  • Haemorrhagic: 20, reflecting a -25.93% change.
  • Ischaemic: 79, a -5.95% change.
  • Not specified as haemorhage or infarction: 22, stable at 0.00%.
  • Transient ischaemic attacks: 38, decreased by -13.64%.
  • Occlusion of cerebral and precerebral arteries: 1, indicating a -50.00% change.

Surgical Admissions

  • Arthroscopy Knee: 142, rose 21.37%.
  • Arthroscopy Shoulder: 27, rose 42.11%.
  • Caesarean Sections: 636, down -6.19%.
  • Cardiac Catheterization Procedures: 0.
  • Cardiac EPS and Ablation: 0.
  • Cataract Surgery: 0.
  • Cholecystectomies: 143, rose 31.19%.
  • Circumcisions: 22, rose 10.00%.
  • Colonoscopies: 577, rose 12.70%.
  • Coronary Artery Bypass Grafts: 0.
  • Cystoscopies: 350, rose 23.67%.
  • Gastroscopies: 1,035, rose 7.81%.
  • Elective Hip Replacements: 41, down -6.82%.
  • Emergency Hip Replacements: 11, down -31.25%.
  • Hysterectomies: 192, rose 6.67%.
  • Knee Replacements: 32, down -8.57%.
  • Myringotomies: 0.
  • Radical Prostatectomy: 1.
  • Spinal Fusions: 87, rose 8.75%.
  • Spinal Laminectomies: 48, down -28.36%.
  • Tonsil & Adenoid Surgery: 3, down -25.00%.
  • Transurethral Resection of Prostate (TURP): 83, rose 3.75%.
  • Valve Replacement (AVR): 0.
  • Valve Implantation (TAVI): 0.

Volumes for Selected Chronic Diseases

  • Hypertension: 4,374, an 8.62% increase.
  • Diabetes Mellitus - Type 1: 324, up 1.89%.
  • Diabetes Mellitus - Type 2: 1,607, a 7.92% increase.
  • Hyperlipidaemia: 1,614, representing a -1.16% change.
  • Asthma: 764, rose 2.55%.
  • Coronary Artery Disease: 534, a 0.75% increase.
  • Cardiac Failure: 1,073, up 3.47%.
  • Hypothyroidism: 412, rose 26.77%.
  • Epilepsy: 751, rose 9.64%.
  • COPD: 423, rose 1.68%.
  • Rheumatoid Arthritis: 174, rose 10.13%.
  • Tuberculosis: 119, reflecting a -8.46% change.
  • HIV: 691, down -19.09%.
  • Malaria: 1, down -50.00%.
  • Hepatitis A, B, C, E: 46, down -53.06%.
  • Pertussis: 0, down -100.00%.
  • Measles: 1, stable at 0.00%.
  • Meningococcal Meningitis: 1.

Age Population Profile

  • Neonates [0-28 days]: 142, rose 11.81%.
  • Infants [29 days - 1 year]: 171, stable at 0.00%.
  • Children [>1 years - 12 years]: 932, rose 9.52%.
  • Adolescents [13 years - 18 years]: 477, down -2.65%.
  • Adults [>18 years - 64 years]: 8,665, rose 4.13%.
  • Geriatrics [>65 years]: 2,186, rose 5.76%.

Body Mass Index (BMI) Categories

  • Underweight (BMI ≤ 18.5): 166, rose 3.75%.
  • Normal Weight (18.5 < BMI ≤ 25.0): 1,458, down -11.85%.
  • Overweight (25.0 < BMI ≤ 30.0): 2,063, down -8.11%.
  • Obese (30.0 < BMI ≤ 40.0): 2,936, stable at 0.00%.
  • Morbidly Obese (BMI > 40.0): 1,076, rose 10.36%.
  • Unclassified: 2,344, rose 44.96%.

Patient Safety Information

  • Patient days: 55,095 up 2.33%.
  • Serious Reportable Events (SRE): 93, up 2.20%.
  • Rate per 1,000 Patient Days: 1.69, down -0.13%.

Harm Levels (per 1,000 PD)

  • Near Misses: 1.31, down -3.62%.
  • No Harm Events: 10.29, up 10.15%.
  • Low Harm Events: 4.12, down -18.75%.
  • Moderate Harm Events: 3.41, up 26.70%.
  • Severe Harm Events: 0.13, up 14.00%.
  • Events Resulting in Death: 1.14, down -9.47%.

Surgical Safety

  • Ward based checks: 84%, down -2.92%.
  • Handover from ward to theatre staff: 100%, a decrease of -0.28%.
  • Sign in Step: 96%, down -1.00%.
  • Time out Step: 97%, down -0.48%.
  • Sign out Step: 95%, down -0.70%.
  • Theatre based checks: 97%, down -0.64%.

Never Events Reported

  • Reported Never Events: 0, down -100.00%.
  • Rate per 1,000 Patient Days: 0.00, down -100.00%.
Types of Never Events
  • Foreign Object(s) Left Behind in Patient: 0.
  • Incorrect Patient (Correct Surgery): 0.
  • Incorrect Surgery (Correct Patient): 0.
  • Incorrect Prosthesis/Implant: 0.
  • Surgery On Wrong Side/Site Performed: 0, down -100.00%.
  • Never Events Other: 0.
  • Unrecognized Abdominopelvic Accidental Puncture/Lacerations: 3, up 50.00%.
  • Number of Abdominopelvic Surgery Cases: 2,938, up 4.04%.
  • Rate per 1,000 Cases: 1.02, up 44.18%.
  • Patient Days per month reported on Invoice Date: 55,095.

Medication Errors

  • Number of Medication Errors: 45, down -26.23%.
  • Rate per 1,000 Patient Days: 0.82, down -27.91%.
    • Prescription Errors: 0.02, down -80.46%.
    • Dispensing Errors: 0.13, down -51.14%.
    • Administration Errors: 0.67, down -13.91%.

Falls

  • Number of Falls (with/without injuries): 63, down -13.70%.
  • Number of Falls (with injuries): 11, up 10.00%.
  • Rate per 1,000 Patient Days: 0.20, up 7.49%.

Hospital Associated Skin Lesions

  • Hospital Associated Skin Lesions: 37, up 42.31%.
  • Rate per 1,000 Patient Days: 0.67, up 39.06%.

Hospital Associated Pressure Injuries

  • Hospital Associated Pressure Injuries: 26, rose 30%.
  • Pressure Injuries Rate per 1,000 Patient Days: 0.47, up 27.03%.
    • Pressure Injuries (Grade 1): 3, down -40.0%.
    • Pressure Injuries (Grade 2): 15, up 15.4%.
    • Pressure Injuries (Grade 3): 1.
    • Pressure Injuries (Grade 4): 0.
    • Pressure Injuries (Unstageable / Unclassified): 0.
    • Suspected Deep Tissue Injury: 7.
    • Pressure Injuries (Grade 1) per 1,000 PD (n): 0.05, decreased -41.37%.
    • Pressure Injuries (Grade 2) per 1,000 PD (n): 0.27, increased 12.75%.
    • Pressure Injuries (Grade 3) per 1,000 PD (n): 0.02
    • Pressure Injuries (Grade 4) per 1,000 PD (n): 0.00
    • Pressure Injuries (Unstageable / Unclassified) per 1,000 PD (n): 0.00
    • Suspected Deep Tissue Injury per 1,000 PD (n): 0.13
  • Number of IV Line Harm Cases: 92, down -30.30%.

Infection Prevention & Control

Key Metrics

  • Total Actions: 784, a -16.42% change.
  • Total Opportunities: 941, reflecting a -12.55% change.
  • Hand Hygiene Compliance Rate: 83.31%, reflecting a -5.86% change.
  • Healthcare Associated Infections: 47, increased 38.24%.
  • HAI Rate per 1,000 Patient Days: 0.85, up 35.08%.
Device Associated Infections
  • Device Associated Infections: 3, down -40%.
  • Ventilator Associated Pneumonia Infections: 3, down -40%.
  • Ventilator Days: 964, down -35%.
  • VAP Rate per 1,000 Ventilator Days: 3.11, decreased by -7.70%.
Central Line Associated Bloodstream Infections
  • Central Line Associated Bloodstream Infections: 5, rose 66.67%.
  • Central Line Days: 6074, increased 18.77%.
  • CLABSI Rate per 1,000 Central Line Days: 0.82, increased 40.32%.
Catheter Associated Urinary Tract Infections
  • Catheter Associated Urinary Tract Infections: 2, down -33.33%.
  • Catheter Days: 9,865, reflecting a -4.28% change.
  • CAUTI Rate per 1,000 Catheter Days: 0.20, decreased by -30.35%.
Surgical Site Infections
  • Surgical Site Infections: 22, rose 15.79%.
  • Operative Procedures: 5,689, rose 6.68%.
  • SSI Rate per 1,000 Operative Cases: 3.87, increased 8.54%.
Specific Surgical Site Infections Rates
  • Surgical Site Infections (Abdom. Hysterectomies): Data not available.
  • Surgical Site Infections (CABG): Data not available.
  • Surgical Site Infections (Knee Replacements): Data not available.
  • Surgical Site Infections (Hip Replacements): Data not available.
  • Surgical Site Infections (Caesarean Sections): Data not available.

Alert Organisms

  • Methicillin Resistant Staph. Aureus (MRSA): Data not available.
    • MRSA (Healthcare Associated): Data not available.
    • MRSA (Community & Healthcare Associated): Data not available.
  • Health. Ass. MRSA Rate per 100,000 PD's: Data not available.

Antimicrobial Stewardship

  • Inappropriate Prophylaxis Cases: 5, increased 25.00%.
  • Theatre Cases with Prophylaxis: 228, increased 21.93%.
  • Inappropriate Prophylaxis Rate (%): 2.19%, increased 2.52%.
  • Prolonged/Extended Treatment Cases: 2, stable at 0.00%.
  • Exposures of Selected Antimicrobials: 1,280, increased 10.25%.
  • Prolonged Treatm. Rate per 1,000 Exposures: 1.56%, decreased -9.30%.
  • Total Antimicrobial Usage (DDD's): 3,649, increased 28.71%.
  • Total Antimicrobial Usage Rate per 100 PD's: 75.90, increased 1.83%.

Targeted Defined Daily Doses (DDD's) Utilisation

  • Polymyxin (Colistin and Polymyxin B) (DDD's): 200, up 0.79%.
    • Rate per 100 Patient Days: 0.36, down -1.51%.
  • Carbapenems (DDD's): 4,079, up 6.06%.
    • Rate per 100 Patient Days: 7.40, up 3.64%.
  • Third Generation Cephalosporins (DDD's): 5,631, up 12.06%.
    • Rate per 100 Patient Days: 10.22, up 9.50%.
  • Fluoroquinolone (DDD's): 2,518, down -2.15%.
    • Rate per 100 Patient Days: 4.57, down -4.38%.
  • Echinocandins (DDD's): 1,130, up 13.95%.
    • Rate per 100 Patient Days: 2.05, up 11.35%.

Clinical Effectiveness Indicators

Overall Mortality Indicators

  • Number of Inpatient Mortalities: 241, rose 19.90%.
  • Inpatient Mortality Rate (%): 2.11%, rose 13.80%.
  • Number of Inpatient Adult Mortalities: 233, rose 19.49%.
  • Inpatient Adult Mortality Rate (%): 2.36%, rose 13.34%.
  • Hospital Standardized Adult Mortality Index: 0.85, rose 14.50%.

Surgical Mortality

  • Number of Surgical Mortalities (Inpatients): 79, rose >100.0%.0%.
  • Surgical Mortality Rate (%): 1.42%, rose 3.94%.

Emergency Centre Mortality

  • Number of Emergency Centre Mortalities: 21, rose 16.67%.
  • Emergency Centre Mortality Rate (%): 0.22%, rose 24.30%.

Patient Transfers

  • Number of Patients Transferred In: 44, rose 57.14%.
  • Mortalities on Transferred In Patients: 0, down -100.0%.
  • Mortality Rate on Transferred In Patients (%): 0.00%, down -100.0%.

Patients Admitted via EC

  • Number of Patients Admitted via EC: 4,606, rose 7.12%.
  • Mortalities on Patients Admitted via EC: 153, rose >100.0%.0%.
  • Mortality Rate on Patients via EC (%): 3.32%, rose 11.59%.

Maternal Mortality

  • Maternal Mortality (WHO Definition): 1, stable at 0.00%.
  • Maternal Mortality Rate per 100,000 Live Births: 122.25, decreased -0.12%.

Adult Critical Care Mortality Indicators

  • Number of Cases Captured on SAPS3: 533, rose 2.70%.
  • Number of Critical Care Mortalities: 167, rose 28.46%.
  • Crude Mortality Rate - Critical Care (%): 31.33%, rose 25.09%.
  • Number of Expected Mortality Cases: 95, down -8.16%.
  • Expected Mortality Rate - Critical Care (%): 17.85%, down -10.58%.
  • Mortality Index (SAPS3): 1.75, rose 39.88%.

Obstetric Indicators

  • Number of Deliveries: 826, decreased -1.31%.
  • Number of Live Births: 818, increased 0.12%.
  • Caesarean Section (%): 72.8%, decreased -4.99%.
  • Weighted Adverse Outcome Score (WAOS): 0.79, decreased -58.65%.
  • Adverse Outcome Index (AOI): 2.7%, decreased -20.38%.
  • Severity Index (SI): 29.8, decreased-48.06%.

Mortality in Neonates and Deliveries

  • Number of Neonatal Mortalities: 0.
  • Neonatal Mortality Rate per 1,000 Live Births: 0.00.
  • Delivery Patient Mortalities: 0, down -100.00%.
  • Delivery Mortality Rate per 100,000 Live Births: 0.00, down -100.00%.

Uterine Measures

  • Uterine Ruptures: 0.
  • Uterine Ruptures (%): 0.00%.

Unplanned Maternal Admissions and Births

  • Unplanned Maternal Admissions to ICU: 3, decreased -25.00%.
  • Unplanned Maternal Admission to ICU (%): 0.36%, decreased -24.00%.
  • Birth Trauma Cases (≥37wks, ≥2.5kg): 0.
  • Birth Trauma (%): 0.00%.
  • Unanticipated Operative Procedures: 0.
  • Unanticipated Operative Procedure (%): 0.00%.

Neonatal Admissions and APGAR scores

  • Neonatal Admissions to NICU (≥37wks, ≥2.5kg, ≥24h): 5, decreased -28.57%.
  • Neonatal Admissions to NICU (%): 0.61%, decreased -27.62%.
  • APGAR score <7 at 5 min (≥37wks, ≥2.5kg): 1.
  • APGAR score < 7 at 5 min (%): 0.12%, increased 1.33%.

Blood Transfusions & Perineal Tears

  • Blood Transfusions: 13, decreased -18.75%.
  • Blood Transfusion (%): 1.57%, decreased -17.67%.
  • 4th Degree Perineal Tears: 0, down -100.00%.
  • 4th Degree Perineal Tear (%): 0.00%, down -100.00%.

Readmission Rate Indicators

  • Overall 30-day Readmissions: 1,170, increased 10.59%.
  • Overall 30-day Readmission Rate (%): 9.31%, increased 5.78%.
  • Overall 15-day Readmissions: 947, increased 8.73%.
  • Overall 15-day Readmission Rate (%): 7.53%, increased 4.00%.
  • Overall 7-day Readmissions: 618, increased 11.96%.
  • Overall 7-day Readmission Rate (%): 4.92%, increased 7.09%.
  • 30-day Adult Readmissions: 1,080, increased 11.69%.
  • Expected 30-day Adult Readmissions: 937, increased 5.59%.
  • 30-day Adult Readmission Index: 1.15, increased 5.77%.

Length of Stay Indicators

  • Overall Extended/Prolonged Stay Cases: 1,643, increased 2.11%.
  • Expected Number of Extended/Prolonged Cases: 1,122, increased 5.10%.
  • Extended/Prolonged Stay Index: 1.47, decreased -2.84%.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Mediclinic Newcastle - Clinical Indicator Report PDF

More Like This

Infant Mortality Quiz
5 questions

Infant Mortality Quiz

HeartwarmingInspiration avatar
HeartwarmingInspiration
The Fetus and the Neonatal Infant Chapter 112 Quiz
12 questions

The Fetus and the Neonatal Infant Chapter 112 Quiz

ExcitingDialogue avatar
ExcitingDialogue
Neonatal Mortality Rate and Maternal Mortality Rate
40 questions

Neonatal Mortality Rate and Maternal Mortality Rate

FeatureRichPlatypus avatar
FeatureRichPlatypus
Neonatal Nursing and Infant Mortality
5 questions

Neonatal Nursing and Infant Mortality

SincerePromethium430 avatar
SincerePromethium430
Use Quizgecko on...
Browser
Open
Browser
Browser